Literature DB >> 7055740

The fate of phenobarbitone in children in hypothermia and at normal body temperature.

D Kadar, B K Tang, A W Conn.   

Abstract

Four critically injured children receiving large doses of phenobarbitone were studied during hypothermia (30 degrees - 31 degrees C) and at normal body temperature. The volume of distribution of phenobarbitone varied from 0.79 to 1.01 litres per kg and the serum t 1/2 ranged from 36.8 +/- 9.4 to 86.2 +/- 10.5 hrs. The percentage of dose recovered in urine in 16 days ranged from 40.5 to 65.5 per cent: 2.7 to 12.4 per cent as hydroxyphenobarbitone, 1.7 to 19.7 per cent as conjugated hydroxyphenobarbitone, 6.0 to 22.4 per cent as phenobarbitone-N-glucoside and 17.8 to 23.1 per cent as unchanged drug. After the body temperature was allowed to return to normal the rate of excretion of metabolites increased substantially and the rate of excretion of the unchanged drug decreased markedly. It is concluded that reduction in body temperature influences the volume of distribution, rate of metabolism and excretion of phenobarbitone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7055740     DOI: 10.1007/bf03007942

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  17 in total

1.  Metabolite of phenobarbital in human urine.

Authors:  E J ALGERI; A J MCBAY
Journal:  Science       Date:  1956-02-03       Impact factor: 47.728

2.  Excretion of phenobarbitone in urine after intake of large doses.

Authors:  A Ravn-Jonsen; M Lunding; O Secher
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1969

3.  Distinctive patterns of amobarbital metabolites.

Authors:  W Kalow; B K Tang; D Kadar; T Inaba
Journal:  Clin Pharmacol Ther       Date:  1978-11       Impact factor: 6.875

4.  Cerebral salvage in near-drowning following neurological classification by triage.

Authors:  A W Conn; J E Montes; G A Barker; J F Edmonds
Journal:  Can Anaesth Soc J       Date:  1980-05

5.  Placental transfer and pharmacokinetics of primidone and its metabolites phenobarbital, PEMA and hydroxyphenobarbital in neonates and infants of epileptic mothers.

Authors:  H Nau; D Rating; I Häuser; E Jäger; S Koch; H Helge
Journal:  Eur J Clin Pharmacol       Date:  1980-07       Impact factor: 2.953

6.  A method for the study of N-glucosidation in vitro--amobarbital-N-glucoside formation in incubations with human liver.

Authors:  B K Tang; G Carro-Ciampi
Journal:  Biochem Pharmacol       Date:  1980-07-15       Impact factor: 5.858

7.  Cerebral resuscitation in near-drowning.

Authors:  A W Conn; J F Edmonds; G A Barker
Journal:  Pediatr Clin North Am       Date:  1979-08       Impact factor: 3.278

8.  Phenobarbital metabolism in adults and in newborn infants.

Authors:  L O Boréus; B Jalling; N Kållberg
Journal:  Acta Paediatr Scand       Date:  1978-03

9.  Phenobarbital pharmacokinetics in neonates.

Authors:  W Pitlick; M Painter; C Pippenger
Journal:  Clin Pharmacol Ther       Date:  1978-03       Impact factor: 6.875

10.  Phenytoin binding to partially purified albumin in renal disease.

Authors:  D W Kinniburgh; N D Boyd
Journal:  Clin Pharmacol Ther       Date:  1981-02       Impact factor: 6.875

View more
  10 in total

Review 1.  Physiologic and pharmacologic considerations for hypothermia therapy in neonates.

Authors:  S Zanelli; M Buck; K Fairchild
Journal:  J Perinatol       Date:  2010-12-23       Impact factor: 2.521

Review 2.  Effects of hypothermia on pharmacokinetics and pharmacodynamics: a systematic review of preclinical and clinical studies.

Authors:  Marcel P H van den Broek; Floris Groenendaal; Antoine C G Egberts; Carin M A Rademaker
Journal:  Clin Pharmacokinet       Date:  2010-05       Impact factor: 6.447

Review 3.  The effect of therapeutic hypothermia on drug metabolism and response: cellular mechanisms to organ function.

Authors:  Jiangquan Zhou; Samuel M Poloyac
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-04-08       Impact factor: 4.481

4.  Initial studies on the N-glucosylation of phenobarbital by mouse liver microsomes using a radiochemical high-performance liquid chromatographic (HPLC) method.

Authors:  W H Soine; H Safi; R B Westkaemper
Journal:  Pharm Res       Date:  1992-05       Impact factor: 4.200

5.  The impact of extracorporeal life support and hypothermia on drug disposition in critically ill infants and children.

Authors:  Enno D Wildschut; Annewil van Saet; Pavla Pokorna; Maurice J Ahsman; John N Van den Anker; Dick Tibboel
Journal:  Pediatr Clin North Am       Date:  2012-08-29       Impact factor: 3.278

6.  Stereochemical characterization of the diastereomers of the phenobarbital N-beta-D-glucose conjugate excreted in human urine.

Authors:  W H Soine; P J Soine; S E Mongrain; T M England
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

Review 7.  Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives.

Authors:  Maria D Donovan; Brendan T Griffin; Liudmila Kharoshankaya; John F Cryan; Geraldine B Boylan
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

8.  Stability of phenobarbital N-glucosides: identification of hydrolysis products and kinetics of decomposition.

Authors:  F B Vest; W H Soine; R B Westkaemper; P J Soine
Journal:  Pharm Res       Date:  1989-06       Impact factor: 4.200

9.  Mild hypothermia alters midazolam pharmacokinetics in normal healthy volunteers.

Authors:  David Hostler; Jiangquan Zhou; Michael A Tortorici; Robert R Bies; Jon C Rittenberger; Philip E Empey; Patrick M Kochanek; Clifton W Callaway; Samuel M Poloyac
Journal:  Drug Metab Dispos       Date:  2010-02-17       Impact factor: 3.922

10.  A novel step-down infusion method of barbiturate therapy: Its safety and effectiveness for intracranial pressure control.

Authors:  Yukako Yamakawa; Motohiro Morioka; Tetsuya Negoto; Kimihiko Orito; Munetake Yoshitomi; Yukihiko Nakamura; Nobuyuki Takeshige; Masafumi Yamamoto; Yasuharu Takeuchi; Kazutaka Oda; Hirofumi Jono; Hideyuki Saito
Journal:  Pharmacol Res Perspect       Date:  2021-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.